A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo
- 1 December 2009
- Vol. 395 (2) , 210-222
- https://doi.org/10.1016/j.virol.2009.09.023
Abstract
No abstract availableKeywords
Funding Information
- Institute for Antiviral Research, IAR (NO1-A1-30048, NO1-AI-15435, 5P01AI059443)
This publication has 99 references indexed in Scilit:
- Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activationJournal of General Virology, 2009
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in miceProceedings of the National Academy of Sciences, 2008
- Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections?: Lack of efficacy of promazine on SARS-CoV replication in a mouse modelAntiviral Research, 2008
- Interferon-inducible antiviral effectorsNature Reviews Immunology, 2008
- Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cellsBiochemical and Biophysical Research Communications, 2008
- C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infectionAntiviral Research, 2008
- The SARS-CoV ferret model in an infection–challenge studyVirology, 2008
- Synthetic Reconstruction of Zoonotic and Early Human Severe Acute Respiratory Syndrome Coronavirus Isolates That Produce Fatal Disease in Aged MiceJournal of Virology, 2007
- SARS coronavirus and innate immunityVirus Research, 2007